KPCB XIII Associates, LLC
CIK 1500595 · last filed 2021-04-19
KPCB XIII Associates, LLC is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for PGNY, was dated Apr 19, 2021. Across all open-market trades the lifetime net is −$23.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $235.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$235.22M
2
4
-$23.31M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PGNY | 10%+ Owner | 8,823,142 | $26.66 | $235.22M | -$1.82M | 2 | 2021-04-19 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 3,838,167 | $1.47 | $5.64M | -$21.48M | 2 | 2014-02-12 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-19 | PGNY | Mixed | +1,018,238 | -$30 | EDGAR |
| 2021-04-01 | PGNY | Other (J) | −90,310 | $0 | EDGAR |
| 2014-02-12 | Epizyme, Inc. (EPZM) Delisted | Sell (S) | −777,168 | -$21.48M | EDGAR |
| 2013-06-07 | Epizyme, Inc. (EPZM) Delisted | Conv (C) | +8,453,502 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.